Albrecht Reith
- Professor emeritus; Dr. med.
- +47 22 93 42 17
Special research interest: Gross genomic abberations as an early event i cancerogenesis.
Publications 2008
Teleradiology with satellite units - six years experience at the norwegian radium hospital
Stud Health Technol Inform, 134, 209-16
PubMed 18376048
Publications 2006
[Retraction of: Diagnostics and treatment of early stages of oral cancer]
Tidsskr Nor Laegeforen, 126 (17), 2287
PubMed 16967079
Publications 2005
Biphasic chromatin structure and FISH signals in reflect intranuclear order
Cell Oncol, 27 (5-6), 327-34
DOI 10.1155/2005/673949, PubMed 16373965
The evolution of predictive oncology and molecular-based therapy for oral cancer prevention
Int J Cancer, 115 (3), 339-45
DOI 10.1002/ijc.20896, PubMed 15688375
Risk markers of oral cancer in clinically normal mucosa as an aid in smoking cessation counseling
J Clin Oncol, 23 (9), 1927-33 (Retracted)
DOI 10.1200/JCO.2005.03.172, PubMed 15774785
Volume-related sequence of tumor distribution pattern in prostate carcinoma: importance of posterior midline crossover in predicting tumor volume, extracapsular extension, and seminal vesicle invasion
Croat Med J, 46 (3), 429-35
PubMed 15861523
Publications 2004
The past of Cellular Oncology
Cell Oncol, 26 (1-2), 1-2
DOI 10.1155/2004/106532, PubMed 15371651
The influence of resection and aneuploidy on mortality in oral leukoplakia
N Engl J Med, 350 (14), 1405-13 (Retracted)
DOI 10.1056/NEJMoa033374, PubMed 15070790
Publications 2003
Information technology in action: the example of Norway
Stud Health Technol Inform, 96, 186-9
PubMed 15061543
Molecular based treatment of oral cancer
Oral Oncol, 39 (8), 749-58 (Retracted)
DOI 10.1016/s1368-8375(03)00098-8, PubMed 13679198
Which putatively pre-malignant oral lesions become oral cancers? Clinical relevance of early targeting of high-risk individuals
J Oral Pathol Med, 32 (2), 63-70
DOI 10.1034/j.1600-0714.2003.00054.x, PubMed 12542827
Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral lesions
Oral Oncol, 39 (5), 497-505 (Retracted)
DOI 10.1016/s1368-8375(03)00012-5, PubMed 12747975
Publications 2002
Impact of genomic instability in risk assessment and chemoprevention of oral premalignancies
Int J Cancer, 101 (3), 205-9
DOI 10.1002/ijc.10569, PubMed 12209969
Gross genomic aberrations in precancers: clinical implications of a long-term follow-up study in oral erythroplakias
J Clin Oncol, 20 (2), 456-62
DOI 10.1200/JCO.2002.20.2.456, PubMed 11786574
When is an oral leukoplakia premalignant?
Oral Oncol, 38 (8), 813-4; author reply 811-2 (Retracted)
DOI 10.1016/s1368-8375(02)00021-0, PubMed 12570065